JS Link, Inc. (KOSDAQ:127120)
29,150
-1,900 (-6.12%)
At close: Feb 6, 2026
JS Link Revenue
JS Link had revenue of 5.17B KRW in the quarter ending September 30, 2025, with 26.37% growth. This brings the company's revenue in the last twelve months to 16.14B, down -15.24% year-over-year. In the year 2024, JS Link had annual revenue of 15.91B, down -27.52%.
Revenue (ttm)
16.14B
Revenue Growth
-15.24%
P/S Ratio
59.03
Revenue / Employee
192.14M
Employees
84
Market Cap
952.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15.91B | -6.04B | -27.52% |
| Dec 31, 2023 | 21.95B | 4.97B | 29.26% |
| Dec 31, 2022 | 16.98B | -6.01B | -26.14% |
| Dec 31, 2021 | 22.99B | 7.71B | 50.41% |
| Dec 31, 2020 | 15.29B | -287.16M | -1.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HansBiomed | 89.78B |
| ROKIT Healthcare | 20.33B |
| S.Biomedics | 16.96B |
| AprilBio | 8.97B |
| Qurient | 8.28B |
| AbClon | 3.80B |
| IntoCell | 1.68B |
| ToolGen | 1.07B |